Global Biosimilar Market 2009 to 2014 Marketsand Markets

Global Biosimilar Market (2009 to 2014) Marketsand. Markets – Analyst Briefing Research Analyst : Kiran Bajaj Moderator: Manisha Shenoy

About us What M&M can do for ABC • • • Key deliverables for ABC – can M&M meet your expectations? Writing bulk market reports Handling consulting assignments Conducting technical research Support database development Flexible business model – M&M value proposition M&M Market Reports – A Quick Insight • • • M&M market research reports snapshot M&M research reports have a worldwide market share of 16. 6% Comparison of M&M reports with third-party reports M&M market reports – types and categories Market intelligence repository – research store of 120 full-length, strategic, and global reports M&M industry experts with experience from renowned publishers Market numbers – M&M reports provide 100+ market data tables Five-level market breakdown Business leader insight – competitive landscape High Level Analysis (HLA) Matching standards- in-house publishing

Agenda for the briefing • Overview of the market • Market trends- Opportunities, Growth factors • Application of biosimilar- Market prospective • Geography Analysis • Competitive scenario

Market transition impacting Biosimilar market

Issues related with biosimilar

Comprehensive market segmentation

Pricing of biosimilar drug

Agenda for the briefing • Overview of the market • Market trends- Opportunities, Growth factors • Application of biosimilar- Market prospective • Geography Analysis • Competitive scenario

Biosimilar product market trend

Biosimilar market dynamics

Agenda for the briefing • Overview of the market • Market trends- Opportunities, Growth factors • Application of biosimilar- Market prospective • Geography Analysis • Competitive scenario

Biosimilar application- Lucrative markets

Agenda for the briefing • Overview of the market • Market trends- Opportunities, Growth factors • Application of biosimilar- Market prospective • Geography Analysis • Competitive scenario

Geography

Agenda for the briefing • Overview of the market • Market trends- Opportunities, Growth factors • Application of biosimilar- Market prospective • Geography Analysis • Competitive scenario

Competitive Landscape MAJOR MARKET PLAYERS MAJOR FOCUSED SEGMENTS MAJOR MARKET STRATEGIES Biocon, Dr. Reddy’s lab, Intas, LG Life Sciences, Ranbaxy, Reliance Life. Sciences, Sandoz, Teva, and Wockhardt Biosimilar erythropoietin, insulin, GCSF, somatotropin, interferon alpha and interferon beta Agreements & Collaborations, New Product/Service Launch

M&M - USP Cu 1 sto 00% mi za ti & s e urc ng o s Re raini T t Fle Mo xibl e d C el os M&M “Industry Knowledge and Prior Experience” “We Are Open To Pilot Testing” ity al k Qu ec Ch “You Fix Our Standards” on Flexible Business Model- Our approach “We Wait For Your Returns”

M&M Contact Details For queries on Biosimilar briefing - Please contact us on kiran@marketsandmarkets. com The Upcoming Reports in the Healthcare division of M&M on the following topics • • • Healthcare IT market Dental Devices market Food Encapsulation market Imaging information systems market Microscopy market Cardiology monitoring and advanced technologies market To let us know any other topics you may be interested in please visit our website http: //www. marketsandmarkets. com/ Or email us on research@marketsandmarkets. com or Sales@marketsansmarkets. com for sales queries or new topics.